Empagliflozin-induced lipidome remodeling in type 2 diabetes: mechanistic insights and translational perspectives
Crossref DOI link: https://doi.org/10.1186/s12933-025-02974-4
Published Online: 2025-11-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Izzo, Carmine
Carrizzo, Albino
Text and Data Mining valid from 2025-11-04
Version of Record valid from 2025-11-04
Article History
Received: 1 October 2025
Accepted: 8 October 2025
First Online: 4 November 2025
Declarations
:
: Not applicable.
: The author declares that there are no competing interests.